1H quantitative NMR and UHPLC-MS analysis of seized MDMA/NPS mixtures and tablets from night-club venues
Literature Information
Husain A. Naqi, Stephen M. Husbands, Ian S. Blagbrough
3,4-Methylenedioxymethamphetamine (MDMA) in the UK has increased in purity and the contents sold as MDMA (ecstasy, E) have increased in complexity. Night-club scenes remain overall the biggest venues where such powders or tablets are consumed. HPLC and GC are the gold standard analytical methods in forensic laboratories for the quantification of seized samples of illicit drugs. However, complex mixtures of such samples may be a limiting factor for chromatographic techniques. NMR is used for the structural elucidation of newly isolated natural products or synthesized compounds, but also the inherent ability of 1H NMR to quantify compounds is a powerful tool that is employed for quantification and purity testing in the pharmaceutical industry. In this study, a 1H quantitative NMR (q-NMR) method is developed for the quantification of seized samples from night-clubs. These samples are shown to contain mixtures of MDMA and other NPS, e.g. ethylone, methylone, trifluoromethylpiperazine (TFMPP), N,N-dimethyl-3,4-methylenedioxyamphetamine (MDDMA), 4-bromo-2,5-dimethoxyphenethylamine (2C-B), and 4-iodo-2,5-dimethoxyphenethylamine (2C-I). The method is applied to MDMA tablets seized from similar venues, and compared with UHPLC and UHPLC-MS, resulting in a good agreement across techniques. 1H q-NMR provides a fast (15 min) and robust analytical method for the quantification of complex seized samples without resorting to tedious sample preparation or obtaining reference standards.
Related Literature
New graphene derivative with N-methylpyrrolidone: suspension, structural, optical and electrical properties
Evgenyi Yakimchuk
DOI: 10.1039/C9CP01612K
Opening 2,2-diphenyl-2H-chromene to infrared light
Benjamin H. Strudwick, Christopher O’Bryen, Hans J. Sanders, Sander Woutersen
DOI: 10.1039/C9CP01906E
Molecular mechanisms of pore formation and membrane disruption by the antimicrobial lantibiotic peptide Mutacin 1140
Rudramani Pokhrel, Nisha Bhattarai, Prabin Baral, Jae H. Park, Martin Handfield
DOI: 10.1039/C9CP01558B
Modifications in coordination structure of Mg[TFSA]2-based supporting salts for high-voltage magnesium rechargeable batteries
Kenji Tatesaka, Kenya Soh, Hyuma Masu, Ashu Choudhary, Ryuta Ise, Hiroaki Imai, Tatsuya Takeguchi, Kiyoshi Kanamura
DOI: 10.1039/C9CP01400D
Block copolymers as bile salt sequestrants: intriguing structures formed in a mixture of an oppositely charged amphiphilic block copolymer and bile salt
Karin Schillén, Luciano Galantini, Guanqun Du, Alessandra Del Giudice, Viveka Alfredsson, Anna M. Carnerup, Nicolae V. Pavel, Giancarlo Masci, Bo Nyström
DOI: 10.1039/C9CP01744E
Coarse-grained simulation studies on the adsorption of polyelectrolyte complexes upon lipid membranes
DOI: 10.1039/C9CP01448A
High bond difference parameter-induced low thermal transmission in carbon allotropes with sp2 and sp3 hybridization
Shenghong Ju, Bin Wen, Yuwen Zhang, Roderick Melnik
DOI: 10.1039/C9CP01029G
On-surface synthesis of 2D COFs on Cu(111) via the formation of thermodynamically stable organometallic networks as the template
Cheng-Xin Wang, Jian-Le Chen, Chen-Hui Shu, Ke-Ji Shi, Pei-Nian Liu
DOI: 10.1039/C9CP01843C
Vibrational spectroscopy of the hexahydrated sulfate dianion revisited: role of isomers and anharmonicities
Harald Knorke, Knut R. Asmis
DOI: 10.1039/C9CP01802F
Giant enhancement of electronic polarizability and the first hyperpolarizability of fluoride-decorated graphene versus graphyne and graphdiyne: insights from ab initio calculations
Xiaojun Li, Jun Lu
DOI: 10.1039/C9CP01118H
You might also like
What are the main uses of 1H-Indazole-6-carbonitrile (CAS: 141290-59-7)?
1H-Indazole-6-carbonitrile finds applications in pharmaceuticals, where it serve...
How should waste containing Dioctyl (2E)-2-butenedioate (CAS: 2997-85-5) be handled?
Waste containing Dioctyl (2E)-2-butenedioate (CAS: 2997-85-5) should be collecte...
What industries use Sodium [(1,2-benzoxazol-3-ylmethyl)sulfonyl]azanide (CAS: 68291-98-5)?
Sodium [(1,2-benzoxazol-3-ylmethyl)sulfonyl]azanide is primarily used in pharmac...
Are there alternatives to Dimethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,6-pyridinedicarboxylate (CAS: 741709-66-0) in synthesis?
Dimethyl 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2,6-pyridinedicarboxyla...
How should waste containing 2-Fluoro-6-hydrazinopyridine (CAS: 80714-39-2) be handled?
Waste containing 2-Fluoro-6-hydrazinopyridine (CAS: 80714-39-2) should be manage...
What is 6-Formyl-2-pyridinecarboxylic acid (CAS: 499214-11-8)?
6-Formyl-2-pyridinecarboxylic acid is an organic compound with the molecular for...
What is the market or research trend for 3-(3,4-dimethoxyphenyl)-2,5-dimethyl-N-(2-morpholin-4-ylethyl)pyrazolo[1,5-a]pyrimidin-7-amine (CAS: 900874-91-1)?
Research trends for this compound indicate a focus on its potential applications...
How is 9H-Tribenzo[b,d,f]azepine (CAS: 29875-73-8) typically synthesized?
9H-Tribenzo[b,d,f]azepine is typically synthesized via a multi-step process invo...
How is 1-Cyclopropyl-7-ethoxy-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid (CAS: 1797982-51-4) typically synthesized?
1-Cyclopropyl-7-ethoxy-6-fluoro-8-methoxy-4-oxo-1,4-dihydro-3-quinolinecarboxyli...
How should waste containing Methyl 3-oxo-1,2,3,4-tetrahydro-6-quinoxalinecarboxylate (CAS: 671820-52-3) be handled?
Waste containing Methyl 3-oxo-1,2,3,4-tetrahydro-6-quinoxalinecarboxylate (CAS: ...
Source Journal
Analytical Methods

Analytical Methods welcomes early applications of new analytical and bioanalytical methods and technology demonstrating the potential for societal impact. We require that methods and technology reported in the journal are sufficiently innovative, robust, accurate, and compared to other available methods for the intended application. Developments with interdisciplinary approaches are particularly welcome. Systems should be proven with suitably complex and analytically challenging samples. We encourage developments within, but not limited to, the following technologies and applications: global health, point-of-care and molecular diagnostics biosensors and bioengineering drug development and pharmaceutical analysis applied microfluidics and nanotechnology omics studies, such as proteomics, metabolomics or glycomics environmental, agricultural and food science neuroscience biochemical and clinical analysis forensic analysis industrial process and method development














